StemCells (STEM +3.6%) moves higher today after launching four new human neural stem cell kits under its SC Proven brand for use in neuroscience research. Each kit will contain high purity, multi-potent neural stem cells derived from a different area of the human central nervous system, and will provide researchers with a platform with which to perform a broad range of assays and tests.
StemCells (STEM +3.6%) moves higher today after launching four new human neural stem cell kits...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs